Clinical Trial Update: Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer [Phase 2]

View source ↗

Summary

University of Kansas Medical Center is sponsoring a Phase 2 neoadjuvant trial comparing THP versus TCHP for HER2-positive breast cancer; the study is not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• PACLITAXEL (PACLITAXEL)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING